ALB and hepatocellular carcinoma: Intriguingly, hierarchical clustering analysis segregated these HCC patients into three distinct subgroups, with one subgroup composed of seven patients reaching 43–56% overlap with the Alb-R26Met list (subgroup-3; Fig. 1f, Supplementary Fig. 3C).